Clinical Trials
24 trialsA Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors
Shandong Boan Biotechnology Co., Ltd
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
Imbioray (Hangzhou) Biomedicine Co., Ltd.
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors
RemeGen Co., Ltd.
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Shandong New Time Pharmaceutical Co., LTD
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
Fujian Cancer Hospital
6MW3511 in Patients With Advanced Solid Tumor
Mabwell (Shanghai) Bioscience Co., Ltd.
A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.
A Phase 1b Study of ZN-c3 in Chinese Subjects
Zentera Therapeutics HK Limited
Microtransplantation for Advanced and Relapsed Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
National Cancer Centre, Singapore
Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
SuZhou Stainwei Biotech Inc.
MASCT-I Treatment for Advanced Solid Tumor
The First People's Hospital of Lianyungang
QoL Phase I
Institut Curie
A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
Threshold Pharmaceuticals
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
Biotech Pharmaceutical Co., Ltd.
A Study of QBI-139 in Subjects With Advanced Solid Tumors
Quintessence Biosciences, Inc.
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Nanjing Luye Sike Pharmaceutical Co., Ltd.
cat´sclaw
Faculdade de Medicina do ABC
Characterisation of Gene Variants in the Angiogenic Pathway
National University Hospital, Singapore
Concurrent Xeloda and Radiotherapy for Bone Metastases
Rambam Health Care Campus